These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 24024153)

  • 61. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
    Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
    J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia.
    Veit G; Bossard F; Goepp J; Verkman AS; Galietta LJ; Hanrahan JW; Lukacs GL
    Mol Biol Cell; 2012 Nov; 23(21):4188-202. PubMed ID: 22973054
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
    Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
    Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.
    Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC
    J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator.
    Cotten JF; Ostedgaard LS; Carson MR; Welsh MJ
    J Biol Chem; 1996 Aug; 271(35):21279-84. PubMed ID: 8702904
    [TBL] [Abstract][Full Text] [Related]  

  • 68. How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
    Zwick M; Esposito C; Hellstern M; Seelig A
    J Biol Chem; 2016 Jul; 291(28):14483-98. PubMed ID: 27226582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
    Li C; Naren AP
    Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator.
    van der Mark VA; de Jonge HR; Chang JC; Ho-Mok KS; Duijst S; Vidović D; Carlon MS; Oude Elferink RP; Paulusma CC
    Biochim Biophys Acta; 2016 Sep; 1863(9):2280-8. PubMed ID: 27301931
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CFTR-PTEN-dependent mitochondrial metabolic dysfunction promotes
    Riquelme SA; Lozano C; Moustafa AM; Liimatta K; Tomlinson KL; Britto C; Khanal S; Gill SK; Narechania A; Azcona-Gutiérrez JM; DiMango E; Saénz Y; Planet P; Prince A
    Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270271
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency.
    Sorio C; Montresor A; Bolomini-Vittori M; Caldrer S; Rossi B; Dusi S; Angiari S; Johansson JE; Vezzalini M; Leal T; Calcaterra E; Assael BM; Melotti P; Laudanna C
    Am J Respir Crit Care Med; 2016 May; 193(10):1123-33. PubMed ID: 26694899
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CFTR: folding, misfolding and correcting the ΔF508 conformational defect.
    Lukacs GL; Verkman AS
    Trends Mol Med; 2012 Feb; 18(2):81-91. PubMed ID: 22138491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Islet-intrinsic effects of CFTR mutation.
    Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
    Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SERCA and PMCA pumps contribute to the deregulation of Ca2+ homeostasis in human CF epithelial cells.
    Philippe R; Antigny F; Buscaglia P; Norez C; Becq F; Frieden M; Mignen O
    Biochim Biophys Acta; 2015 May; 1853(5):892-903. PubMed ID: 25661196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
    Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pseudomonas aeruginosa-induced bleb-niche formation in epithelial cells is independent of actinomyosin contraction and enhanced by loss of cystic fibrosis transmembrane-conductance regulator osmoregulatory function.
    Jolly AL; Takawira D; Oke OO; Whiteside SA; Chang SW; Wen ER; Quach K; Evans DJ; Fleiszig SM
    mBio; 2015 Feb; 6(2):e02533. PubMed ID: 25714715
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure and function of the cystic fibrosis transmembrane conductance regulator.
    Morales MM; Capella MA; Lopes AG
    Braz J Med Biol Res; 1999 Aug; 32(8):1021-8. PubMed ID: 10454765
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
    Boucherle B; Bertrand J; Maurin B; Renard BL; Fortuné A; Tremblier B; Becq F; Norez C; Décout JL
    Eur J Med Chem; 2014 Aug; 83():455-65. PubMed ID: 24992073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.
    Chen JH
    J Biol Chem; 2020 Apr; 295(14):4577-4590. PubMed ID: 32102849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.